Detalles de la búsqueda
1.
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
Cardiovasc Drugs Ther
; 2022 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36445624
2.
Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial.
Clin Trials
; 17(5): 491-500, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32815416
3.
Sealing Intermediate Nonobstructive Coronary Saphenous Vein Graft Lesions With Drug-Eluting Stents as a New Approach to Reducing Cardiac Events: A Randomized Controlled Trial.
Circ Cardiovasc Interv
; 9(11)2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815344
4.
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
J Am Coll Cardiol
; 42(8): 1380-6, 2003 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-14563578
5.
Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction--the RADIAL-AMI pilot randomized trial.
Am Heart J
; 150(3): 543-9, 2005 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-16169338
Resultados
1 -
5
de 5
1
Próxima >
>>